Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a consumer health company focused on everyday health brands (e.g., Advil, Centrum, Panadol), covers the month of June 2026. The report, dated June 8, 2026, details transactions in the company's own shares under a share buyback programme announced on March 12, 2026.
Key Financial Metrics and Share Transactions
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity:
- Total Shares Purchased: 16,585,448 ordinary shares for cancellation.
- Transaction Period: June 1, 2026, to June 4, 2026 (no purchases on June 5).
- Price Range: Highest price paid was 334.10 pence; lowest price paid was 317.90 pence.
- Post-Transaction Capital: Registered share capital is 8,842,752,346 ordinary shares of £0.01 each.
- Treasury Shares: 12,063,502 shares held as treasury shares.
- Voting Rights: 8,830,688,844 ordinary shares with voting rights.
Material Changes
The primary material change is the reduction in the number of outstanding shares due to the cancellation of 16,585,448 shares purchased during the first week of June 2026. The filing does not provide comparative data against prior periods for these specific transaction volumes.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operational performance, or discussion of risks and contingencies. It is a regulatory disclosure of share transactions required under the Market Abuse Regulation (EU) No 596/2014 as applied in the UK. The announcement explicitly states it does not constitute an offer or solicitation of securities.
Investor Verification Checklist
- Verify the total number of shares purchased (16,585,448) against the company's broader buyback programme limits.
- Confirm the updated number of voting shares (8,830,688,844) for disclosure threshold calculations under FCA rules.
- Review the full breakdown of individual trades via the provided London Stock Exchange link for granular pricing analysis.
- Note that this filing does not contain financial performance data; refer to Form 20-F or quarterly reports for revenue and profit metrics.